Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

  • Filters activated: Cancer. Clear all to show 16 items.
1.

Ganodermanontriol inhibits expression of special AT rich sequence binding protein 1 gene in human hepatocellular carcinoma.

Xu C, Guo H, Kong D, Pang D, Ding Y.

J Cancer Res Ther. 2018 Dec;14(Supplement):S964-S968. doi: 10.4103/0973-1482.203597.

2.

Triterpenoids from Ganoderma lucidum inhibit the activation of EBV antigens as telomerase inhibitors.

Zheng DS, Chen LS.

Exp Ther Med. 2017 Oct;14(4):3273-3278. doi: 10.3892/etm.2017.4883. Epub 2017 Aug 3.

3.

Tubulin polymerization-stimulating activity of Ganoderma triterpenoids.

Kohno T, Hai-Bang T, Zhu Q, Amen Y, Sakamoto S, Tanaka H, Morimoto S, Shimizu K.

J Nat Med. 2017 Apr;71(2):457-462. doi: 10.1007/s11418-017-1072-y. Epub 2017 Jan 11.

PMID:
28078535
4.

Effects of Ganodermanondiol, a New Melanogenesis Inhibitor from the Medicinal Mushroom Ganoderma lucidum.

Kim JW, Kim HI, Kim JH, Kwon OC, Son ES, Lee CS, Park YJ.

Int J Mol Sci. 2016 Oct 27;17(11). pii: E1798.

5.

Distinct Responses of Cytotoxic Ganoderma lucidum Triterpenoids in Human Carcinoma Cells.

Ruan W, Wei Y, Popovich DG.

Phytother Res. 2015 Nov;29(11):1744-52. doi: 10.1002/ptr.5426. Epub 2015 Aug 21.

PMID:
26292672
6.

In vitro and in vivo hepatoprotective effect of ganodermanontriol against t-BHP-induced oxidative stress.

Ha do T, Oh J, Khoi NM, Dao TT, Dung le V, Do TN, Lee SM, Jang TS, Jeong GS, Na M.

J Ethnopharmacol. 2013 Dec 12;150(3):875-85. doi: 10.1016/j.jep.2013.09.039. Epub 2013 Oct 17.

PMID:
24140584
7.

Semisynthesis and biological evaluation of ganodermanontriol and its stereoisomeric triols.

Kennedy EM, P'Pool SJ, Jiang J, Sliva D, Minto RE.

J Nat Prod. 2011 Nov 28;74(11):2332-7. doi: 10.1021/np200205n. Epub 2011 Nov 1.

PMID:
22044278
8.

Ganodermanontriol (GDNT) exerts its effect on growth and invasiveness of breast cancer cells through the down-regulation of CDC20 and uPA.

Jiang J, Jedinak A, Sliva D.

Biochem Biophys Res Commun. 2011 Nov 18;415(2):325-9. doi: 10.1016/j.bbrc.2011.10.055. Epub 2011 Oct 18.

PMID:
22033405
9.

Pharmacophore-based discovery of FXR-agonists. Part II: identification of bioactive triterpenes from Ganoderma lucidum.

Grienke U, Mihály-Bison J, Schuster D, Afonyushkin T, Binder M, Guan SH, Cheng CR, Wolber G, Stuppner H, Guo DA, Bochkov VN, Rollinger JM.

Bioorg Med Chem. 2011 Nov 15;19(22):6779-91. doi: 10.1016/j.bmc.2011.09.039. Epub 2011 Sep 29.

10.

Ganodermanontriol, a lanostanoid triterpene from Ganoderma lucidum, suppresses growth of colon cancer cells through ß-catenin signaling.

Jedinak A, Thyagarajan-Sahu A, Jiang J, Sliva D.

Int J Oncol. 2011 Mar;38(3):761-7. doi: 10.3892/ijo.2011.898. Epub 2011 Jan 11.

PMID:
21225227
11.

New triterpene aldehydes, lucialdehydes A-C, from Ganoderma lucidum and their cytotoxicity against murine and human tumor cells.

Gao JJ, Min BS, Ahn EM, Nakamura N, Lee HK, Hattori M.

Chem Pharm Bull (Tokyo). 2002 Jun;50(6):837-40.

12.

Triterpene antioxidants from ganoderma lucidum.

Zhu M, Chang Q, Wong LK, Chong FS, Li RC.

Phytother Res. 1999 Sep;13(6):529-31.

PMID:
10479768

Supplemental Content

Loading ...
Support Center